Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Covid-19 and the Potential of Janus Family Kinase (Jak) Pathway Inhibition: A Novel Treatment Strategy Publisher



Khaledi M1 ; Sameni F1 ; Yahyazade S2 ; Radandish M2 ; Owlia P3 ; Bagheri N4 ; Afkhami H5 ; Mahjoor M6 ; Esmaelpour Z7 ; Kohansal M8 ; Aghaei F4
Authors

Source: Frontiers in Medicine Published:2022


Abstract

Recent evidence proposed that the severity of the coronavirus disease 2019 (COVID-19) in patients is a consequence of cytokine storm, characterized by increased IL-1β, IL-6, IL-18, TNF-α, and IFN-γ. Hence, managing the cytokine storm by drugs has been suggested for the treatment of patients with severe COVID-19. Several of the proinflammatory cytokines involved in the pathogenesis of COVID-19 infection recruit a distinct intracellular signaling pathway mediated by JAKs. Consequently, JAK inhibitors, including baricitinib, pacritinib, ruxolitinib, and tofacitinib, may represent an effective therapeutic strategy for controlling the JAK to treat COVID-19. This study indicates the mechanism of cytokine storm and JAK/STAT pathway in COVID-19 as well as the medications used for JAK/STAT inhibitors. Copyright © 2022 Khaledi, Sameni, Yahyazade, Radandish, Owlia, Bagheri, Afkhami, Mahjoor, Esmaelpour, Kohansal and Aghaei.
Related Docs
View other Related Docs
1. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
2. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
3. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
Experts (# of related papers)
View all Related Experts
Laleh Shariati (2)
Ilnaz Rahimmanesh (2)
Other Related Docs
4. Subcutaneous Tocilizumab in Adults With Severe and Critical Covid-19: A Prospective Open-Label Uncontrolled Multicenter Trial, International Immunopharmacology (2020)
5. Cancer Occurrence As the Upcoming Complications of Covid-19, Frontiers in Molecular Biosciences (2022)
6. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
7. Cytokine Profiles Dynamics in Covid-19 Patients: A Longitudinal Analysis of Disease Severity and Outcomes, Scientific Reports (2025)
8. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
9. The Role of Serum Circulating Microbial Toxins in Severity and Cytokine Storm of Covid Positive Patients, Microbial Pathogenesis (2023)
10. Immune Responses to Corona Family Viruses and Vaccine Strategies, Journal of Isfahan Medical School (2020)
11. Selective Serotonin Reuptake Inhibitors: New Hope in the Fight Against Covid-19, Frontiers in Pharmacology (2022)
12. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
13. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
14. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
15. Clinical Profile, Outcome and Management of Kidney Disease in Covid-19 Patients - a Narrative Review, European Review for Medical and Pharmacological Sciences (2022)
16. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies, Journal of Experimental and Clinical Medicine (Turkey) (2022)
17. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
18. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
19. Covid-19 Pandemic: Insights Into Genetic Susceptibility to Sars-Cov-2 and Host Genes Implications on Virus Spread, Disease Severity and Outcomes, Human Antibodies (2022)
20. N-Acetylcysteine and Coronavirus Disease 2019: May It Work As a Beneficial Preventive and Adjuvant Therapy? a Comprehensive Review Study, Journal of Research in Medical Sciences (2020)